| Company/Division name | Co-Diagnostics |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Total number of jobs (added or to be added): | 400 |
| Year reshoring announced: | 2023 |
| Year reshoring implemented or to be implemented: | 2024 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 8.97 |
| City reshored to: | South Salt Lake |
| State(s) reshored to: | UT |
| If relevant, work nearshored to: | - |
| Industry(ies): | Computer & Electronic Products, Medical Equipment & Supplies |
| Product(s) reshored | polymerase chain reaction (molecular) testing |
| What domestic positive factors made reshoring more attractive? | Customization/Flexibility, Higher productivity, Proximity to customers/market |
